A Study of IBI351 in Combination With Cetuximab in Subjects With KRAS G12C Mutated Metastatic Colorectal Cancer
Clinical trial NCT05497336 · TERMINATED
Trial details
- NCT number
- NCT05497336
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-18
- Primary completion
- 2025-01-24
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.